A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
Clinical trial NCT06786312 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06786312
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-25
- Primary completion
- 2027-07-25
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.